Nadel J A
Cardiovascular Research Institute, Department of Medicine, University of California, San Francisco, CA 94143-0130, USA.
Respir Res. 2001;2(2):85-9. doi: 10.1186/rr43. Epub 2001 Feb 21.
Healthy individuals have few goblet cells in their airways, but in patients with hypersecretory diseases goblet-cell upregulation results in mucus hypersecretion, airway plugging, and death. Multiple stimuli produce hypersecretion via epidermal growth factor receptor (EGFR) expression and activation, causing goblet-cell metaplasia from Clara cells by a process of cell differentiation. These cells are also believed to be the cells of origin of non-small-cell lung cancer, but this occurs via cell multiplication. The mechanisms that determine which pathway is chosen are critical but largely unknown. Although no effective therapy exists for hypersecretion at present, the EGFR cascade suggests methods for effective therapeutic intervention.
健康个体气道中的杯状细胞较少,但在分泌亢进性疾病患者中,杯状细胞上调会导致黏液分泌过多、气道阻塞和死亡。多种刺激通过表皮生长因子受体(EGFR)的表达和激活产生分泌亢进,通过细胞分化过程使克拉拉细胞发生杯状细胞化生。这些细胞也被认为是非小细胞肺癌的起源细胞,但这是通过细胞增殖发生的。决定选择哪条途径的机制至关重要,但很大程度上尚不清楚。尽管目前尚无针对分泌亢进的有效疗法,但EGFR级联反应提示了有效的治疗干预方法。